BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+13.01%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.91T
AUM Growth
+$437B
(+13%)
Cap. Flow
+$36.3B
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
22.4%
Holding
5,487
New
93
Increased
3,052
Reduced
1,506
Closed
171
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.56B |
| 2 |
Uber
UBER
|
+$2.21B |
| 3 |
Apple
AAPL
|
+$2.11B |
| 4 |
Amazon
AMZN
|
+$2.1B |
| 5 |
Microsoft
MSFT
|
+$1.99B |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$5.15B |
| 2 |
VMW
VMware, Inc
VMW
|
+$2.9B |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$2.56B |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.72B |
| 5 |
Danaher
DHR
|
+$1.11B |
Sector Composition
| 1 | Technology | 27.22% |
| 2 | Healthcare | 12.82% |
| 3 | Financials | 12.11% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Pioneer Bancorp
PBFS
$338M
| $6.83M | ﹤0.01% |
681,829
+63,352
| +10% | +$634K |
|
3427
National CineMedia
NCMI
$455M
| $6.76M | ﹤0.01% |
1,632,835
+123,891
| +8% | +$513K |
|
3428
ESS Tech
GWH
$20.2M
| $6.75M | ﹤0.01% |
394,838
+19,170
| +5% | +$328K |
|
|
AKYA
3429
DELISTED
Akoya BioSciences
AKYA
| $6.7M | ﹤0.01% |
1,372,232
-72,770
| -5% | -$355K |
|
3430
Puma Biotechnology
PBYI
$225M
| $6.69M | ﹤0.01% |
1,544,532
+68,821
| +5% | +$298K |
|
3431
Mammoth Energy Services
TUSK
$114M
| $6.68M | ﹤0.01% |
1,496,945
+120,935
| +9% | +$539K |
|
|
VNET
3432
VNET Group
VNET
$2.57B
| $6.51M | ﹤0.01% |
2,269,267
-130,699
| -5% | -$375K |
|
3433
EVI Industries
EVI
$348M
| $6.47M | ﹤0.01% |
272,788
+19,026
| +7% | +$451K |
|
3434
Bank7 Corp
BSVN
$455M
| $6.47M | ﹤0.01% |
236,682
+34,104
| +17% | +$933K |
|
3435
iShares US Equity Factor ETF
LRGF
$2.9B
| $6.46M | ﹤0.01% |
133,773
+6,830
| +5% | +$330K |
|
3436
Citius Pharmaceuticals
CTXR
$20.6M
| $6.4M | ﹤0.01% |
338,313
+26,867
| +9% | +$508K |
|
3437
FibroGen
FGEN
$48.6M
| $6.39M | ﹤0.01% |
288,212
-33,216
| -10% | -$736K |
|
|
DNMR
3438
DELISTED
Danimer Scientific, Inc.
DNMR
| $6.37M | ﹤0.01% |
156,215
+10,079
| +7% | +$411K |
|
|
IGMS
3439
DELISTED
IGM Biosciences
IGMS
| $6.34M | ﹤0.01% |
762,470
-108,446
| -12% | -$901K |
|
3440
Esperion Therapeutics
ESPR
$573M
| $6.32M | ﹤0.01% |
2,112,899
+145,020
| +7% | +$434K |
|
3441
Babcock & Wilcox
BW
$281M
| $6.32M | ﹤0.01% |
4,325,873
+282,686
| +7% | +$413K |
|
|
ASAI
3442
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $6.31M | ﹤0.01% |
456,420
+2,490
| +0.5% | +$34.4K |
|
3443
Design Therapeutics
DSGN
$343M
| $6.31M | ﹤0.01% |
2,380,242
-23,673
| -1% | -$62.7K |
|
|
PPTA
3444
Perpetua Resources
PPTA
$1.86B
| $6.28M | ﹤0.01% |
1,982,009
+154,916
| +8% | +$491K |
|
3445
AN2 Therapeutics
ANTX
$35M
| $6.27M | ﹤0.01% |
305,841
+263,679
| +625% | +$5.4M |
|
3446
Rentokil
RTO
$12.8B
| $6.21M | ﹤0.01% |
217,140
-61,870
| -22% | -$1.77M |
|
3447
Aclaris Therapeutics
ACRS
$211M
| $6.2M | ﹤0.01% |
5,905,872
+297,982
| +5% | +$313K |
|
|
RPT
3448
Rithm Property Trust Inc.
RPT
$124M
| $6.2M | ﹤0.01% |
1,168,992
-309,249
| -21% | -$1.64M |
|
3449
Cue Biopharma
CUE
$57M
| $6.17M | ﹤0.01% |
2,338,765
+209,815
| +10% | +$554K |
|
3450
Protalix BioTherapeutics
PLX
$144M
| $6.15M | ﹤0.01% |
3,457,734
+282,272
| +9% | +$502K |
|